Prediction of drug-like properties of the lead molecules by QikProp Maestro 11.2 molecular docking suitea.
| S. no. | Sample ID | QP log Po/w (−2.0 to 6.5) | QP log HERG (acceptable range: above −5.0) | QPP Caco (nm s−1) (<25 is poor, >500 is good) | QP log BB (−3 to 1.2) | QPP MDCK (nm s−1) (<25 is poor, >500 is good) | QP log Kp (−8.0 to −0.1) | QP log Khsa (acceptable range: −1.5 to 1.5) | Percentage human oral absorption (<25% is low, >80% is high) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 5a | 2.318 | −4.879 | 411.852 | −1.037 | 150.21 | −2.226 | 0.068 | 89.62 |
| 2 | 5b | 2.317 | −4.876 | 411.352 | −1.138 | 168.31 | −2.998 | 0.071 | 89.67 |
| 3 | 5c | 2.798 | −4.768 | 376.133 | −0.787 | 373.182 | −2.967 | 0.168 | 90.32 |
| 4 | 5d | 2.762 | −4.789 | 376.164 | −0.767 | 465.314 | −3.012 | 0.207 | 90.67 |
| 5 | 5e | 2.497 | −4.766 | 318.637 | −0.982 | 154.32 | −2.997 | 0.209 | 89.13 |
| 6 | 5f | 2.231 | −4.812 | 399.258 | −0.813 | 199.87 | −2.175 | 0.098 | 88.32 |
| 7 | 6a | 2.499 | −5.612 | 417.253 | −1.040 | 192.330 | −2.998 | 0.072 | 88.48 |
| 8 | 6b | 2.499 | −5.538 | 417.07 | −1.141 | 192.141 | −3.084 | 0.073 | 88.47 |
| 9 | 6c | 2.804 | −5.622 | 417.156 | −0.798 | 473.982 | −3.057 | 0.177 | 90.26 |
| 10 | 6d | 2.881 | −5.654 | 417.294 | −0.791 | 509.985 | −3.059 | 0.2 | 90.71 |
| 11 | 6e | 2.621 | −5.632 | 417.097 | −0.984 | 192.252 | −3.086 | 0.219 | 89.19 |
| 12 | 6f | 2.497 | −5.602 | 413.143 | −0.870 | 292.220 | −2.992 | 0.102 | 88.40 |
Ligand CID, PubChem IDs of the lead molecules; Ligand STOCK, Updated library of natural compounds, InterBioScreen (IBS) library; Predicted IC50 value for blockage of HERG K+ channels (acceptable range: above −5.0); QPP Caco, predicted apparent Caco-2 cell permeability in nm s−1 (<25 is poor, >500 is good). Caco-2 cells are a model of the gut-blood barrier; QP log BB, predicted brain/blood partition coefficient; QPP MDCK, predicted apparent MDCK cell permeability in nm s−1 (<25 is poor, >500 is good). MDCK cells are considered to be a good mimic of the blood–brain barrier; QP log Kp, predicted skin permeability; QP log Khsa, prediction of binding to human serum albumin (acceptable range: −1.5 to 1.5); percentage human oral absorption (<25% is low, >80% is high).